NEW YORK, Nov. 20, 2013 /PRNewswire-iReach/ -- Large vein occlusive disease is on the rise, especially in diabetic patients. Management of deep vein thrombosis (DVT) of the upper extremity due to thoracic outlet syndrome compressing the subclavian vein and of the lower extremity due to iliac vein stenosis remains controversial. Media is invited to attend any and all presentations relative to large vein occlusive disease presented at the 40th Annual VEITHsymposium in New York. The session will commence on Thursday, November 21st, 1:00 P.M. to 5:00 P.M. located in Americas Hall I, 3rd Floor of the New York Hilton-Midtown (NY, NY). Kenneth Ouriel, MD, MBA, FACS, FACC will moderate the session.
Dr. Ouriel said, "This session will be particularly interesting to the media. We will discuss state-of-the-art diagnostic and treatment modalities for large vein occlusion in the upper and lower extremities. Therapy for axillo/subclavian and lower extremity venous stenotic and occlusive disease continues to evolve, with accumulating data on pharmacologic, mechanical, and open surgical modalities. There is much to be learned." Media will have an opporunity to interview presenters in the VEITHsymposium press office.
The recent advent of stents engineered specifically for the venous anatomy and physiology provides a timely setting to discuss the indications and early outcome of endovascular therapy for venous occlusion. Lastly, clinicians who are highly skilled in these demanding procedures will present the indications and operative techniques for major open surgical reconstruction of the vena cava and other large veins.
Ouriel concluded, "In short, accumulating data on large vessel venous occlusion affords opportunities for the patient and the vascular practitioner alike. Newly gained knowledge of the disease and the results of treatment can be applied to a larger proportion of the underserved population with venous disease; at the same time expanding the armamentarium of effective interventions available to the practicing clinician."
Experts will address the unmet needs and opportunities for the future, other commonly encountered venous occlusive problems and their treatment, treatment of lower extremityDVT, balloons, stents, thrombolysis, ultrasound thrombolysis, mechanical thrombectomy, and inferior vena caval issues (including endovascular and open surgical management).
About VEITHsymposium: Now in its fourth decade, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features over 750 rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. To register to attend the VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780 or email.
Media Contact: Pauline Mayer, PTM Healthcare Marketing, Inc., 631-979-3780, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com